AHNAK2 and breast cancer: Subtype associations varied: MUC16 and AHNAK2 only associated with mRNA abundance differences in luminal B breast cancers, PIK3CA only affected mRNA in luminal A and luminal B breast cancer patients but not HER2-enriched breast cancer patients and TP53 consistently associated with mRNA abundance differences (Fig. 6a).